Olopatadine HCL 0.1% Ophthalmic Solution
SPE2D222R0117 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, performed in Ontario, Canada. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
Questions
What is solicitation SPE2D222R0117?
Olopatadine HCL 0.1% Ophthalmic Solution, issued by DEPT OF DEFENSE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING), performed in Ontario, Canada.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.